Mara B. Antonoff

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

Neostar Trial, Medicine, Immune Checkpoint Inhibitor +6

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang, Reza J. Mehran, Lei Feng et al. · The Lancet Oncology · 2021 · 304 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +8

Does Tweeting Improve Citations? One-Year Results From the TSSMN Prospective Randomized Trial

Jessica G.Y. Luc, Michael A. Archer, Rakesh C. Arora et al. · The Annals of Thoracic Surgery · 2020 · 215 citations

Altmetrics, Computational Social Science, Social Media +10

Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer

Robert M. Van Haren, Reza J. Mehran, Gabriel E. Mena et al. · The Annals of Thoracic Surgery · 2018 · 193 citations

Lung Transplantation, Cardiac Complications, Medicine +7

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 191 citations · Full text